Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Commercial dose non-sterile liquid and semi-solid products, such as ointments, gels, and topical creams,  offer a number of advantages to users, such as individual dosing,

Bay­er is eas­ing in­to the cell ther­a­py space through the open­ing of its first ded­i­cat­ed man­u­fac­tur­ing fa­cil­i­ty in Berke­ley, CA, to sup­port lat­er-stage clin­i­cal tri­als